<p>Cholesterol Efflux Mediator™ VAR 200 is in phase 2a development to reduce renal cholesterol and lipid accumulation that damages the kidneys’ filtration system in patients with glomerula
<p>From a Goldman Sachs note on Thursday afternoon US time – are unconcerned about unionized workers getting wage hikes, saying these are a laggin indicator:</p><ul><li>R
Leave a Comment